# Provisional independent-review status

Initial review-policy record, 2026-10-29.

This is the historical pre-submission record. For the subsequent inspected packages, individual verdicts and remaining blockers, see [the Stage 0/1 package review](STAGE01_VERDICTS.md). The initial inspection state below is preserved, not a claim that no package has now been reviewed.

**Overall: NOT READY. No strategy is recommended or certified safe.**

The judge has defined evidence gates but has not yet independently inspected a complete strategy evidence package. The table records missing/unreviewed evidence, not measured performance. No return, profitability estimate, event probability, or achievable income is asserted here. The source of the research constraints is the user brief, recorded in the [research charter](../docs/CHARTER.md); thresholds are not empirical results.

| Candidate | Initial verdict | Blocking evidence |
| --- | --- | --- |
| Diversified stablecoin lending benchmark | NOT READY | Current and historical rates, feasible allocation, accrued net yield and independent cost/risk review not yet verified |
| Cross-chain relaying / intent filling | NOT READY | Actor attribution/PnL, entrant access/capture, complete T2/T3 and independent cost/risk reviews not yet verified |
| Inventory-based cross-chain DEX arbitrage | NOT READY | Obtainable post-competition opportunities, inventory/cost reconciliation, complete T2/T3 and independent cost/risk reviews not yet verified |
| Long-tail DEX arbitrage | NOT READY | Actor universe, liquidity/impact and eligibility, complete T2/T3 and independent cost/risk reviews not yet verified |
| Backrunning via order-flow auctions | NOT READY | Accessible order flow, auction competition and costs, complete T2/T3 and independent cost/risk reviews not yet verified |
| Smaller-market liquidations | NOT READY | Historical liquidation state, competitor arrival and failed costs, complete T2/T3 and independent cost/risk reviews not yet verified |
| Intent auction solver | NOT READY | Admission/bonds, attainable fills and settlement economics, complete T2/T3 and independent cost/risk reviews not yet verified |
| Delta-neutral funding / basis | NOT READY | Hedge/funding history, custody and liquidation paths, complete T2/T3 and independent cost/risk reviews not yet verified |
| Hedged concentrated-liquidity LP | NOT READY | Fees versus inventory/LVR/hedge costs, full-capital accounting, complete T2/T3 and independent cost/risk reviews not yet verified |
| Fixed / variable yield trading | NOT READY | Tradable maturity-specific yields, exit/roll costs and collateral, complete T2/T3 and independent cost/risk reviews not yet verified |
| Keeper / automation bounties | NOT READY | Eligibility, obtainable jobs and net payout history, complete T2/T3 and independent cost/risk reviews not yet verified |
| CEX-DEX arbitrage | NOT READY | CEX dependence, incumbent speed/capture, full trade costs, complete T2/T3 and independent cost/risk reviews not yet verified |

## Interpretive rules

- Missing actor evidence means no verified T1 package in the judge's reviewed set, not that no profitable actors exist.
- A strategy may be provisionally kept for research before final recommendation gates pass; label that decision RESEARCH CONTINUE rather than recommended.
- Incomplete elapsed forward observation cannot be repaired by replaying history faster or backfilling live data.
- The brief's p5 drawdown screen does not substitute for its stricter monthly 99% drawdown requirement. Unknown tail confidence blocks certification.
- A chain/protocol/issuer/bridge cap must hold at whole-portfolio level, including collateral, reserves and unsettled balances.
- No final investment ranking is appropriate until a comparable feasible benchmark and complete evidence packages are reviewed.

## Next independent action

Inspect immutable submissions from the strategy, capacity, cost and red-team authors; apply [the audit rubric](AUDIT_RUBRIC.md) and [package checklist](PACKAGE_CHECKLIST.md). Record exact inspected claims and blockers before writing any strategy-specific `verdict.md`.
